Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -185,000 | -575,000 | -446,444 | -266,031 | -151,000 |
| Depreciation Amortization | 7,000 | 31,000 | 22,731 | 14,829 | 7,000 |
| Accounts receivable | 19,000 | -31,000 | 2,834 | -2,591 | 10,000 |
| Other Working Capital | -51,000 | -23,000 | -23,588 | -78,447 | -56,000 |
| Other Operating Activity | 13,000 | 132,000 | 78,296 | 57,492 | 24,000 |
| Operating Cash Flow | $-197,000 | $-466,000 | $-366,171 | $-274,748 | $-166,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 258,000 | 329,582 | 210,794 | N/A |
| PPE Investments | -1,000 | -6,000 | -5,062 | -3,784 | -1,000 |
| Purchase Of Investment | -131,000 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 88,000 | N/A | N/A | 143 | 137,000 |
| Purchase Sale Intangibles | -5,000 | -15,000 | -15,000 | -15,000 | -15,000 |
| Other Investing Activity | -5,000 | -16,000 | -16,273 | -16,088 | -16,000 |
| Investing Cash Flow | $-49,000 | $236,000 | $308,247 | $191,065 | $120,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 86,000 | 83,808 | 83,806 | N/A |
| Other Financing Activity | 0 | 392,000 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $478,000 | $83,808 | $83,806 | $N/A |
| Exchange Rate Effect | -1,000 | 4,000 | 4,656 | 4,362 | 1,000 |
| Beginning Cash Position | 436,000 | 184,000 | 184,159 | 184,159 | 184,000 |
| End Cash Position | 189,000 | 436,000 | 214,699 | 188,644 | 139,000 |
| Net Cash Flow | $-247,000 | $252,000 | $30,540 | $4,485 | $-45,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -197,000 | -466,000 | -366,171 | -274,748 | -166,000 |
| Capital Expenditure | -1,000 | -6,000 | -5,062 | -3,784 | -1,000 |
| Free Cash Flow | -198,000 | -472,000 | -371,233 | -278,532 | -167,000 |